Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis

Clinical trial NCT05716035 · UNKNOWN

Trial details

NCT number: NCT05716035
Sponsor: Tang-Du Hospital
Status: UNKNOWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myasthenia Gravis, Generalized

Start date: 2023-04-01
Primary completion: 2024-07-31
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.